SPECTRAL CAPITAL Corp (FCCN): M&A transaction — Spectral Capital acquires plasmonics IP from Verdant Quantum for 10M shares; appoints Dr. Cohen CTO

SPECTRAL CAPITAL Corp

Acquired plasmonics/quantum nanophotonics IP from Verdant Quantum in exchange for 10M common shares; post-deal shares outstanding ~81.7M.
Dr. Moshik Cohen appointed CTO with $240k salary, up to $1M bonus, and options to purchase 2M shares vesting over 4 years.
Technology enables near-light-speed data transfer, low power consumption, and room-temperature operation, per company.
Upon NASDAQ/NYSE listing, Spectral commits to invest $25M into Verdant IL on milestone basis with mutually agreed budget.
Company transitions from QaaS to deep-tech holding company with practical quantum computing IP.

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

SPECTRAL CAPITAL Corp completed an acquisition involving Verdant Quantum, OÜ for 10,000,000 common shares of Spectral (closed 2024-12-16).

Action: acquisition
Counterparty: Verdant Quantum, OÜ
Consideration: 10,000,000 common shares of Spectral
Closing: 2024-12-16

Exact text from the filing

Asset Purchase of Quantum Nanophotonics Technology On December 16, 2024, the Company entered into a Definitive Acquisition Agreement (“ Agreement ”) with Verdant Quantum, OÜ (“ Verdant ”), an Estonian company and Moshik Cohen, whereby the Company acquired technology owned by Verdant related to plasmonics and quantum nanophotonics for use in the development of devices that significantly accelerate the functional processor speed of classical computers (the “ IP ”).

View on SEC.gov

9 m&a transactions filed in the last 30 days. Browse all m&a transactions →

SPECTRAL CAPITAL Corp filing history →

Source: SEC EDGAR

accession 0001096906-24-002279

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.